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Abstract. Background/Aim: To evaluate the research trends in
coronavirus disease (COVID-19). Materials and Methods: A
bibliometric analysis was performed using a machine learning
bibliometric methodology. Information regarding publication
outputs, countries, institutions, journals, keywords, funding and
citation counts was retrieved from Scopus database. Results: A
total of 1883 eligible papers were returned. An exponential
increase in the COVID-19 publications occurred in the last
months. As expected, China produced the majority of articles,
followed by the United States of America, the United Kingdom
and Italy. There is greater collaboration between highly
contributing authors and institutions. The “BMJ” published the
highest number of papers (n=129) and “The Lancet” had the
most citations (n=1439). The most ubiquitous topic was
COVID-19 clinical features. Conclusion: This bibliometric
analysis presents the most influential references related to
COVID-19 during this time and could be useful to improve
understanding and management of COVID-19.
The coronavirus disease (COVID-19) pandemic puts
unprecedented pressures on healthcare systems worldwide
(1). Extensive measures to reduce and prevent its
transmission have been implemented (1). As COVID-19
spreads rapidly, the research community has been active in
publishing novel articles on this dreadful disease. In this
scenario, a bibliometric analysis of the current COVID-19
landscape can improve clinicians’ understanding of the large
and growing body of evidence on the topic. 
Bibliometric analysis is a statistical evaluation of scientific
publications and represents an effective method to measure
and quantitatively describe their influence in clinical practice
over time (2).
Here we present a bibliometric analysis of the publications
on COVID-19. The aim is to identify the trends of present
studies and provide some directions for future research.
Materials and Methods 
A comprehensive search of Scopus database was performed, using
“COVID-19” as research criteria. Literature search was refined to
include manuscripts published between December 1, 2019 and April
20, 2020. Statistical analysis was carried out using R-Studio
0.98.1091 software. A machine learning bibliometric methodology
was applied to evaluate the distribution of each factor. The
bibliometrix R package was used (2). The following variables were
used: citation information – author(s), document title, year, source
title, volume, issue, pages, citation count, source and document
type, bibliographical information, affiliations, editor(s), keywords
and funding details (number, acronym, sponsor).
Results
In total, 1883 documents matched the choice criteria across
9 document types. The 9 document types were article
(n=821), letter (n=308), editorial (n=267), note (n= 28),
review (n=209), short survey (n=26), erratum (n=21),
conference paper (n=2) and data paper (n=1).
Publications came from 94 countries worldwide. The most
productive country in the Covid-19 research field was China,
with a publication share of 30 % (n=565). The United States
of America ranked second (n=368, 19.5%), followed by the
United Kingdom (n=218, 11.6%), Italy (n=143, 7.6%) and
France (n=74, 3.9%). The remaining top 20 most productive
countries were mostly in Europe and Asia. Figure 1 displays
country collaborations. The network diagram – each node
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Figure 1. Country collaboration.
Figure 2. The top twenty relevant affiliations.
represented a country, node size corresponded to publications
number, connecting lines represented country cooperation
and line thickness indicated collaboration frequencies –
showed that China was the leader in COVID-19 research in
cooperation with other countries. Overall, developed
countries had greater collaboration networks than developing
territories.
The distribution of the most productive authors reiterated
the predominance of China in the COVID-19 research field.
The most productive institution was the Huazhong
University of Science and Technology, accounting for 4.8%
(n=91) of the entire documents on this topic (Figure 2). The
1883 articles were published in 644 journals, with 400
journals publishing only one article. The “BMJ” headed the
list with a total number of 129 publications, followed by
“The Lancet” journal (n=3) and the “Journal of medical
virology” (n=60). When analyzed publications’ reference
lists, the most cited sources were “The Lancet” and “The
New England Journal of Medicine” in 1439 articles and 1014
articles, respectively. Overall, the three most common author
keywords were COVID-19 with 475 occurrences,
coronavirus with 219 occurrences and SarsCov2 with 217
occurrences. Figure 3 summarizes these results matching the
most productive countries (on the left), the most relevant
author keywords (in the middle) and the most relevant
sources (on the right).
Table I lists the top 10 cited papers (3-12). The number of
citations ranged from 533 for Huang et al. – “Clinical
features of patients infected with 2019 novel coronavirus in
Wuhan, China.” (3) – to 88 for Wu et al. – “A new
coronavirus associated with human respiratory disease in
China” (12) –. The Lancet had the most citations (n=4 and
1253 citations). Overall, clinical characteristic was the topic
most widely studied (n=8) (3-7, 9-10, 12). One manuscript
examined the genomic features and one study analyzed
infection transmission from asymptomatic contact (8, 11). 
The National Natural Science Foundation of China was the
most productive funding agency with 85 funded articles,
followed by the National Basic Research Program of China
and the National Institutes of Health, with 21 funded articles
and 20 funded articles, respectively.
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Figure 3. Summary plot matching the most productive countries (on the left), the most relevant author keywords (in the middle) and the most relevant
sources (on the right).
Discussion
The aim of this bibliometric analysis was to summarize and
analyze the evolution of the immediate impact of the COVID-
19 pandemic on scientific production. We presented a body of
publications that quantified country-specific and worldwide
coverage of COVID-19 literature at present. The volume and
focus of publications showed a notable increase in the overall
number of documents during the study period. There were
extensive intra- and inter-collaboration networks between
highly productive authors and institutions. Results confirmed
a rapid sharing of data from China and defined the clinical
features of COVID-19 patients as the most common topic.
This is not surprising considering that COVID-19 infection
was first reported in Wuhan City (China) and mainly caused
serious respiratory disease (13). Chinese experience represented
the scientific basis for the development of management
strategies all over the world. This approach was powerful in
helping to train local staff and bring clinical services online. It
is important to recognize the interdisciplinary usefulness –
involving medical science, social science, engineering and
economics – to solve the problem. A comprehensive knowledge
is crucial for the development of an adequate approach that
could be deployed quickly and operated with ease. For instance,
with the development of the pandemic, the asymptomatic
presentation has become one of the focus of research to prevent
the COVID-19 transmission. The more information on virus
pathogenesis can be shared, the more rapidly specific treatments
can be developed. 
The main limitation of this paper is its intrinsic bias. It
was based on Scopus database and we recognized that results
may differ according to other databases or the inclusion of
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Table I. The most cited papers on COVID-19.
Title                                                                                                     Authors                    Year                               Journal                              Citations (n)
Clinical features of patients infected with 2019 novel                    Huang                    2020                           The Lancet                                  533
coronavirus in Wuhan, China (3)                                                        et al.
A novel coronavirus from patients with                                              Zhu                       2020                  New England Journal                        346
pneumonia in China, 2019 (4)                                                             et al.                                                         of Medicine
Epidemiological and clinical characteristics of 99                            Chen                      2020                           The Lancet                                 295
cases of 2019 novel coronavirus pneumonia in                                 et al.
Wuhan, China: A descriptive study (5)
A familial cluster of pneumonia associated with the                        Chan                      2020                           The Lancet                                 235
2019 novel coronavirus indicating person-to-person                        et al.
transmission: a study of a family cluster (6)
A pneumonia outbreak associated with a new                                   Zhou                      2020                               Nature                                     211
coronavirus of probable bat origin (7)                                                et al.
Genomic characterisation and epidemiology of                                  Lu                        2020                           The Lancet                                 190
2019 novel coronavirus: implications for virus                                 et al.
origins and receptor binding (8)
First case of 2019 novel coronavirus in                                          Holshue                    2020                  New England Journal                        147
the United States (9)                                                                            et al.                                                         of Medicine 
Characteristics of and important lessons from                                    Wu                        2020                               JAMA                                     128
the coronavirus disease 2019 (COVID-19)                                        et al.
outbreak in China: Summary of a report of 
72314 cases from the Chinese Center for 
Disease Control and Prevention (10)
Transmission of 2019-ncov infection from an                                   Rothe                      2020                  New England Journal                        122
asymptomatic contact in Germany (11)                                              et al.                                                         of Medicine
A new coronavirus associated with human                                         Wu                        2020                               Nature                                      88
respiratory disease in China (12)                                                         et al.
other search terms. But, to our knowledge, there has been no
recent comprehensive bibliometric analysis of COVID-19
publications. In our opinion, there was an urgent need to
combine this information to derive the best benefit for the
human population. Our bibliometric analysis provides not
only a descriptive quantitative analysis, but also evidence
that implementation and scale-up of networks are feasible.
To conclude, a similar analysis can be useful to empower
countries to develop and sustain better health care by
establishing a more robust collaboration network, including
low-income countries. All the important aspects in terms of
COVID-19 epidemiology, virology, diagnosis and clinical
characteristics should be actively shared to stimulate
researchers to work with local and international groups of
professionals.
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